000 | 01240 a2200349 4500 | ||
---|---|---|---|
005 | 20250513225131.0 | ||
264 | 0 | _c20001222 | |
008 | 200012s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(00)03239-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan den Bosch, F | |
245 | 0 | 0 |
_aCrohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. _h[electronic resource] |
260 |
_bLancet (London, England) _cNov 2000 |
||
300 |
_a1821-2 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Letter | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aCrohn Disease _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aSpondylitis, Ankylosing _xcomplications |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aKruithof, E | |
700 | 1 | _aDe Vos, M | |
700 | 1 | _aDe Keyser, F | |
700 | 1 | _aMielants, H | |
773 | 0 |
_tLancet (London, England) _gvol. 356 _gno. 9244 _gp. 1821-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(00)03239-6 _zAvailable from publisher's website |
999 |
_c11058627 _d11058627 |